The mortality rates at 72 hours and 28 days of life and the incidence of major complications of prematurity were comparable to those found with the animal-derived surfactants commercially available in Brazil , showing the efficacy and safety of the new surfactant in the treatment of respiratory distress syndrome in newborns .